Data as of Sep 19
| 0.00 / 0.00%|
The 6 analysts offering 12-month price forecasts for Galena Biopharma Inc have a median target of 6.00, with a high estimate of 8.00 and a low estimate of 3.00. The median estimate represents a +173.97% increase from the last price of 2.19.
The current consensus among 6 polled investment analysts is to Buy stock in Galena Biopharma Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.